Metraipolis › archive › dc_53906aaaa560

Immune-Based Biomarkers as Predictors of Mortality in ECMO Therapy for Severe COVID-19 ARDS: Insights from a Retrospective Study — Europe PMC PMID:41516267

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41516267
DOI
10.3390/ijms27010390
License (as archived)
solo-consultazione
Archived
2026-11-07T07:52:20.228Z
SHA-256 of the archived text
882313939f5ece91c8bbec3636d63f6de41e00e36f6cf154d10780279da688d3
Stable URL of this page
https://metraipolis.com/documento/dc_53906aaaa560

How to cite

Immune-Based Biomarkers as Predictors of Mortality in ECMO Therapy for Severe COVID-19 ARDS: Insights from a Retrospective Study — Europe PMC PMID:41516267 — Europe PMC (en), https://europepmc.org/article/MED/41516267 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_53906aaaa560 (Metraipolis archive dc_53906aaaa560, sha256 882313939f5ece91c8bbec3636d63f6de41e00e36f6cf154d10780279da688d3)
BibTeX
@misc{dc53906aaaa560,
  title = {Immune-Based Biomarkers as Predictors of Mortality in ECMO Therapy for Severe COVID-19 ARDS: Insights from a Retrospective Study — Europe PMC PMID:41516267},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41516267},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_53906aaaa560; sha256 882313939f5ece91c8bbec3636d63f6de41e00e36f6cf154d10780279da688d3},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41516267. Agents can read the archived copy with the MCP tool read_document.